Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Document reference
number
Document developed by National Stroke
Programme
Approval for
publication date
Document approved by
National Stroke Register Report 2017
National Stroke Programme
August 2018
2
Executive Summary
Introduction
The 2017 National Stroke Register Annual Report is the sixth report since its inception in 2012 and it
continues to reflect the increased commitment to data collection and reporting. The data used for this
analysis is based on routinely collected HIPE data and on additional data inputted onto the stroke portal
by individual hospitals. We remain thankful for the on-going support of the Clinical Nurse Specialists and
Advanced Nurse Practitioners who continue to collect and report data on stroke patients. The National
Stroke Register remains under the governance of a National Stroke Register Steering Group, however, it
remains without any data analytic or research support and the National Stroke Programme continues to
work towards finding a solution for the long term governance of the register. We strongly recommend
that the governance of the National Stroke Register sits within a Quality Improvement framework and
are working with NOCA to support us in this endeavour.
Results
This report presents an analysis of all cases that were discharged from acute public hospitals between
January 1st and December 31st 2017 with a principal diagnosis of Intracerebral Haemorrhage (i61) or
Cerebral Infarction (i63) that have additional stroke register data recorded in >80% of cases .
19 acute public hospitals met this criteria and the sample size obtained for analysis is 3,481 which is
similar to 2015 and 2016. Of those hospitals, HIPE data identified a total of 4205 cases of Cerebral
Infarction or Intracerebral Haemorrhage, of these, 3726 were entered into the National Stroke Register
in 2017 which gives a coverage rate of 89% across all 19 hospitals. As in previous reports there remains
concerns around the completeness of the data and this is reflected in the reduced cohort for analysis in
some areas e.g. onset times and medical review times.
Demographics
The demographic data reported is consistent by and large with that found in the 2015 Irish Heart
foundation / HSE National Stroke Audit (McElwaine et al 2015) with 75% of strokes occurring in over
65s. The proportion of strokes occurring in men of working age rose slightly from 26% in 2016 to 28%.
Data recorded on time of onset suggests high levels of ‘wake-up’ or unwitnessed stroke with time of
onset recorded as ‘unknown’ in 40% of cases. The date and time of stroke onset was only recorded in
3
54% of cases therefore caution is advised when reviewing onset to admission results, however, there is
a trend towards delayed hospital arrival in rural areas, >3hrs in eight hospitals. This would support the
need for increased public awareness campaigns such as the FAST campaign. The UK SSNAP 2017 report
have a known time of onset in 68% of cases with a median time to hospital arrival of 2hrs 50 mins (IQR
1:28-8:46) slightly increased on Irish results of 2hrs 36mins (IQR 1:28-8:46).
Acute Stroke Treatment
Hospital arrival date and time was available in 95% of cases which is a good sample to allow analysis of
acute stroke treatment.
In terms of delivery of acute treatment, 69% of patients were seen by the stroke team within 3hrs of
admission increased from 54% in 2016.
Data on thrombolysis was available in 98% of ischaemic stroke (i63, i64) cases. Thrombolysis was
administered in 11.9 % of cases of cerebral infarction in this stroke population. 271 patients received
endovascular thrombectomy in either Beaumont Hospital or Cork University Hospital.
Data on antithrombotic therapy and atrial fibrillation (AF) is reported in 92% of cases. Of those with
known AF 47% were not on anticoagulation pre-stroke. On discharge, inclusive of pre-existing and new
diagnosis AF, 93% of patients were anticoagulated. There appears to be a strong preference (17:1) for
non-vitamin K antagonist oral anticoagulants (NOACs).
70.6 % of patients were admitted to an acute stroke unit and spent a median of 9 days in a stroke unit.
Data on stroke severity and intensity of rehabilitation is not captured so comparisons about stroke unit
length of stay cannot be made. However, data that suggests the quality of care in stroke units is higher
given that patients are three times more likely to have a swallow screen and a mood screen compared
to those who do not access stroke unit care. 81% of stroke patients are reviewed by the multidisciplinary
team, similar to 2016, however, the data does not interrogate the intensity of therapy. The new HSCP
dataset commenced in 2018 will record more detail in this domain.
Outcomes
This is the first report where we have outcome data based on the Modified Rankin Score (MRS). 71% of
cases have a pre-stroke and discharge MRS and results will be monitored over time.
Challenges remain in our definition of mortality when comparing to other European figures where 30-
day mortality or standardised mortality ratios are often used. In-hospital mortality, in this sample,
without a standardised mortality ratio is 14.2%. When mortality is reported by stroke type, ischaemic
stroke mortality is 10.8% and haemorrhagic stroke is 36.2%. This is comparative to HIPE data for 2017.
The accuracy of the data related to discharge to nursing home remains a concern. An analysis of HIPE
discharge destination to nursing home (15.8%) compared to the discharge destination recorded in the
stroke portal (7.5%) is conflictual and could be explained to some extent by discharge to non-acute
hospital. The NSP will continue to work with the Health Pricing Office in this matter.
4
Recommendations
This registry report highlights that patient presentation times to hospital after symptom onset
remain poor and the need for a sustained public health campaign on stroke.
Door to CT remains challenging and needs ongoing Quality Improvement (QI) focus in hospitals.
Thrombolysis rates remain low in some hospitals although this is also impacted by delayed
presentations.
Admission rates to an acute stroke unit are inadequate against a national target of 90% and
highlights the need for both a stroke unit capacity review and a stroke unit accreditation
process.
Overall the data coverage of the national register continues to improve but work remains to
ensure a more complete capture particularly from large centres missing in this report, and to
understand the gap between registry and HIPE stroke case finding.
Definition of stroke and stroke mortality need universal agreement.
While reassuringly the 2017 data seems consistent with previous reports and the findings of the
2015 Irish Heart Foundation /HSE National Stroke Audit, the National Stroke Register now needs
appropriate professional governance structures to ensure it is GDPR compliant and can become
a sustainable professional audit responsive to the data needs of individual stroke services and
the country to monitor trends, highlight service needs, effect change and allow for international
comparison.
Ronan Collins, Clinical Lead, National Stroke Programme
Joan McCormack, Programme Manager, National Stroke Programme
25/9/18
5
Table of Contents
EXECUTIVE SUMMARY ........................................................................................................................................... 2
INTRODUCTION ..................................................................................................................................................... 6
METHOD ................................................................................................................................................................ 7
RESULTS ................................................................................................................................................................. 9
DEMOGRAPHICS ............................................................................................................................................................. 9
ADMISSION/DISCHARGE DATA........................................................................................................................................ 11
Admission Type ................................................................................................................................................... 11
Admission Source and Discharge Destination ..................................................................................................... 11
Stroke Onset and Admission ............................................................................................................................... 13
Hospital Length of Stay ....................................................................................................................................... 15
STROKE CARE .............................................................................................................................................................. 15
Assessment by Stroke Team ................................................................................................................................ 15
Brain Scanning (CT or MRI) ................................................................................................................................. 16
Thrombolysis ....................................................................................................................................................... 17
Thrombectomy .................................................................................................................................................... 19
Antithrombotic therapy ...................................................................................................................................... 19
Atrial Fibrillation ................................................................................................................................................. 20
ADMISSION TO STROKE UNIT .......................................................................................................................................... 21
Swallow Screening in Stroke Units ...................................................................................................................... 22
Mood Screening .................................................................................................................................................. 23
Stroke Unit Length of Stay (LOS) ......................................................................................................................... 23
OUTCOMES ................................................................................................................................................................. 24
MRS and Stroke Type .......................................................................................................................................... 24
Multidisciplinary Team Assessment .................................................................................................................... 25
APPENDICES......................................................................................................................................................... 27
APPENDIX 1. NATIONAL STROKE REGISTER STEERING GROUP MEMBERS................................................................................. 27
APPENDIX 2. NATIONAL STROKE REGISTER DATASET ........................................................................................................... 28
REFERENCES ......................................................................................................................................................... 33
6
Introduction The National Clinical Programme for Stroke was launched in 2010 and included nine different work
streams, one of which was the development of a National Stroke Register. The National Stroke Register
was developed in partnership with the Health, Research and Information Division at the Economic and
Social Research Institute (ESRI)1. The Register is considered a fundamental component of integrated
stroke services being developed by the National Clinical Programme for Stroke project team. It is essential
to measure the effect of the implementation of the National Clinical Programme for Stroke, in addition to
providing data for planning and estimation of resource requirements for stroke services, evaluation and
clinical audits, and hospital accreditation. The Register was developed and is governed by a Steering Group
derived from the project team, together with expert input from the Healthcare Pricing Office, clinical
practitioners, coding managers and the Irish Heart Foundation Council on Stroke (Appendix 1).
The National Stroke Register was developed within the existing HIPE data collection system. The
Healthcare Pricing Office provides an ‘add-on screen’ to HIPE where the stroke team enters the data
(Appendix 2) while the patient is still in hospital. This is merged automatically with the HIPE discharge
record to provide enhanced information on the hospital care of the stroke patient.
Hospitals commenced participation in the National Stroke Register on a phased basis, with 24 hospitals
currently participating out of the 27 that were provided with access to the Stroke Register. It is noted that
some hospitals are not yet entering data on all acute stroke patients although this is improving over time.
While there is no clear evidence of bias, i.e. hospitals submitting data on patients with the mildest or most
severe strokes, an element of caution is advised in interpreting the data. In 2017, both Connolly Hospital
and Kerry University Hospital commenced data entry and full year data will be presented for both services
in 2018.
1 From January 1st 2014 the National Casemix Programme and the Health Research & Information
Division at the ESRI became the Healthcare Pricing Office (HPO
7
Method
Coverage is the term used to describe the proportion of stroke patients discharged from a hospital with
an ICD 10 code of i61, i63 or i64 that have additional data inputted onto the National Stroke Register.
Table 1. Identifies all HIPE cases that were discharged from acute public hospitals between January 1st
and December 31st 2017 and the cases with additional stroke register data.
Table 1. 2017 HIPE i61, i63, i64 cases with additional NSR data.
This report presents an analysis of all National Stroke Register cases that were discharged from acute
public hospitals between January 1st and December 31st 2017, with approximately 80% coverage, with a
principal diagnosis of Intracerebral Haemorrhage or Cerebral Infarction. Analysis is based on the
aggregate data of these 19 hospitals and measured against previous annual reports and comparative data
from the UK SSNAP 2017 results. For the purposes of this annual report, as was the case for the all previous
reports data are presented on Intracerebral Haemorrhage and Cerebral Infarction patients, based on the
cohort of patients that have been assigned a principal diagnosis in HIPE of Intracerebral Haemorrhage
(ICD-10 I61) or Cerebral Infarction (ICD-10 I63), table 2.
Hospital HIPE Cases i61, i63, i64
Registered Cases i61, i63, i64 Coverage
St Luke’s Hospital Kilkenny 114 114 100%
Cavan General Hospital 166 165 99%
Letterkenny University Hospital 194 192 99%
Bantry General Hospital 57 54 98%
Our Lady of Lourdes Drogheda 194 188 97%
University Hospital Waterford 132 126 95%
University Hospital Galway 318 300 94%
Mercy University Hospital 111 103 93%
Mayo University Hospital 203 185 91%
Tallaght University Hospital 257 233 91%
St Vincent’s University Hospital 339 302 89%
Beaumont Hospital 641 556 87%
Midland Regional Hospital Mullingar 133 116 87%
Wexford General Hospital 157 135 86%
Sligo University Hospital 179 153 85%
Naas General Hospital 174 143 82%
St James’s Hospital 268 217 81%
Portiuncula Hospital 82 66 80%
Cork University Hospital 486 378 78%
South Tipperary General Hospital Clonmel 124 80 65%
Our Lady’s Hospital Navan 81 31 38%
Mater Misericordiae University Hospital 357 94 27%
University Hospital Limerick 359 35 10%
Grand Total 5126 3966 77%
8
Table 2. 2017 NSR data i61, i63, i64 cases
*Beaumont Hospital had 174 cases recorded within HIPE and the NSR that were admitted for thrombectomy
and were transferred back to the referring hospital without admission. These cases have been excluded from
this analysis.
For the time period in question, there
were 4, 784 discharges recorded in the
National Stroke Register across the 19
hospitals. However, not all of the 4,784
cases recorded on the National Stroke
Register were ultimately assigned a
principal diagnosis of Intracerebral
Haemorrhage or Cerebral Infarction in
HIPE. When cases coded as TIA or
recorded as in-patient strokes are
excluded it is found that 10.9% of cases
recorded on the stroke register did not
have a primary diagnosis of stroke (figure
1). The i64 Cerebral Infarction
Undifferentiated was recorded in 114
(4%) of cases. Figure 1. Stroke Register Case
Hospital Total
Registered Cases
I61, i63, i64
Registered Cases
Final Dataset for analysis Registered
Cases i61, i63 St Luke’s Hospital Kilkenny 126 114 114
Cavan General Hospital 182 165 153
Letterkenny University Hospital 374 192 191
Bantry General Hospital 61 56 56
Our Lady of Lourdes Drogheda 201 188 185
University Hospital Waterford 148 126 121
University Hospital Galway 464 313 312
Mercy University Hospital 123 103 96
Mayo University Hospital 243 185 183
Tallaght University Hospital 255 233 214
St Vincent’s University Hospital 363 302 275
Beaumont Hospital* 666 582 408*
Midland Regional Hospital Mullingar 174 116 107
Wexford General Hospital 175 135 122
Sligo University Hospital 195 153 144
Naas General Hospital 183 143 143
St James’s Hospital 309 218 218
Portiuncula Hospital 92 66 65
Cork University Hospital 450 378 374
Total 4784 3769 3481
77%
6%
2%4%
2% 1%
8%
Stroke Register Case HIPE Codes n4784
PDx Stroke i61, i63,
TIA
PDx i64
In-patient Stroke
2nd Dx Stroke
3rd Dx Stroke
Other
If the aggregate data from these 19 hospitals is used for any comparison by individual hospitals it is important that stroke teams:
Compare like with like by only analyzing cases with a principal diagnosis of Intracerebral Haemorrhage (ICD-10 I61) or Cerebral Infarction (ICD-10 I63)
Consider the implications of differences between national and local demographic profiles
9
Results
In this report the data are presented in table format along with a brief commentary. The analysis is
broken down into a number of sections:
Demographics
Admission/discharge data
Acute Stroke Interventions
Stroke Unit Care
Outcome
Demographics
As in all previous reports, over half, 56.5 % of all stroke cases coded as ICD-10 I61 or I63 in the 19
hospitals in 2017 were male (table 3). This is similar to the gender breakdown when compared to the
Irish Heart Foundation/HSE National Stroke Audit 2015 where males accounted for 57% of stroke cases
(McElwaine et al, 2015). This figure was 52% in the Irish National Audit of Stroke Care in 2008 (Horgan et
al, 2008).
Table 3: Gender (n=3,481)
There remains some differences in age profile by gender (table 3).
The mean age for males was 71.8 years and for females it was 73.1 years Irish National Audit of Stroke
Care 2008 found 72 years males, 78 years female (Horgan et al, 2008).
Table 4: Age Profile (%) (n=3,481)
N %
Male 1967 56.5
Female 1514 43.5
<65 Years 65 – 79 Years 80+ Years Mean (±SD)
Male 27.9 43.3 28.8 (70.6 ± 13.3)
Female 18.4 35.9 45.7 (75.5 ± 13.7)
10
Figure 2: Age Profile Figure 3: Mean age of stroke patients by gender 2012-2017
Using data from the 2012 to 2017 the trend in mean age by gender is shown in (Figure 3). While most
strokes occur in those aged 65 years and over, 28% of male strokes occur in working age an increase from
26% in 2016 (figure 4). With regard to females the proportion of strokes occurring in the under 65 age
group appears to be increasing 17.2% in 2013 to 18.4% in 2017 (figure 5).
Figure 4: Male strokes by age group 2012 to 2017
Figure 5: Female strokes by age group 2012 to 2017
27.9
43.3
28.8
18.4
35.9
45.7
0
10
20
30
40
50
<65yrs 65-79yrs 80+
Age Profile 2017
Male Female
6065707580
2006(INASC)
2012 2013 2014 2015 2016 2017
Male and Female Age Profile Trends
Male Female
0
20
40
60
2006(INASC)
2012 2013 2014 2015 2016 2017
Male Strokes by Age Trend
<65 65-79 80+
0
20
40
60
80
2006(INASC)
2012 2013 2014 2015 2016 2017
Female Stroke by Age Trend
<65 65-79 80+
11
Admission/Discharge Data
HIPE records data on a number of variables relating to the admission and discharge of each patient, such
as the type of admission (e.g. elective or emergency), admission source and discharge destination. The
patient’s length of stay is also collected, in addition to clinical codes recording what diagnoses were made
during the hospital stay.
Admission Type
As expected, the vast majority (98%) of stroke cases registered were classified as emergency admissions
(table 5).
Table 5: Admission Type of Stroke Register cases (n=3,481)
N %
Emergency 3413 98 Elective 30 0.86 Emergency readmission 17 0.48 Elective readmission 21 0.60
Admission Source and Discharge Destination
Analysing admission source without any other morbidity or stroke severity data does not inform to any
great extent. However, it does provide useful information when analysed in conjunction with discharge
destination to provide data on outcomes for stroke patients. The admission source data for cases entered
onto the National Stroke Register (table 6) shows that the majority of stroke patients (90.3%) are living at
home prior to their stroke.
Table 6: Admission Source (n=3,481)
N %
Home 3,144 90.3 Acute hospital Transfers 176 5.1 Nursing home 137 3.9 Non-acute Hospital Transfers
8 0.2
Temporary place of residence Other
13 3
0.4 0.1
12
Table 7 outlines the discharge destination of cases as coded by HIPE and also the discharge destination as
recorded within the NSR. HIPE data is complete while the NSR has 85% (2956/3481) coverage. In 2016, an
anomaly was identified in the coding of patients going to nursing homes and to external rehabilitation
facilities. The comparative data suggests that there is variance in how cases are coded particularly when
discharged to nursing home and/or rehabilitation facilities. The National Stroke Programme is working
with the Health Pricing Office to correct this anomaly. At present, the discharge to nursing home data
should be viewed with caution as it is more probable that it is a lower rate than the 15.8% recorded in
HIPE.
Table 7: Discharge Destination
HIPE n=3481
Stroke Register n=2956 (525 missing)
N % N %
Home 1854 53.3 1697 57.4 Nursing home 550 15.8 221 7.5 Died 493 14.2 429 14.5 Transfer to acute hospital – Non-emergency 303 8.7 175 6.0 Emergency hospital transfer 105 3.0 Transfer to external rehab – non-HIPE facility 130 3.7 399 13.5 Transfer to non-acute hospital 15 0.4 Other 3 0.1 35 1.1 Hospice 4 0.1 Temporary Residence 5 0.1 Self-discharge 13 0.4 Absconded 2 0.1 Transfer to Psychiatric Hospital 4 0.1
Within the NSR cohort the in-hospital mortality rate was 14.2%. The Irish Heart Foundation/HSE National
Stroke Audit 2015 reported a mortality rate of 14% and the Sentinel Stroke National Audit Programme,
SSNAP (Royal College of Physicians 2017) report a 14.3% in-hospital mortality rate. When reported by
stroke type the NSR shows that the mortality for ischaemic stroke is 10.8% (326/3019) and 36.2%
(167/462) for haemorrhagic stroke.
13
Figure 6. National Mortality Rates NQAIS 2015-2017
Figure 6. indicates the mortality based on
stroke type using the National Quality
Assurance & Improvement System (NQAIS)
of all i61, i63 and i64 cases from 2015 to
2017. These results reflect the correlation
between NSR results and national HIPE data
results.
Caution is advised in comparing Irish
mortality rates with International and
National mortality rates in stroke, such as
the National Audit of Hospital Mortality
(NAHM) and the National Healthcare
Quality Reporting System (NHQRS) as data
is adjusted for casemix.
Stroke Onset and Admission
While HIPE records date of admission to hospital, time of admission is not recorded. Stroke teams are
asked to enter hospital arrival date and hospital arrival time. This can then be used to calculate delays to
hospital arrival from stroke onset in hours and minutes, which is more appropriate for stroke care when
“Time is Brain”.
However, both the date and time for stroke onset and hospital arrival must be known and recorded in
order to calculate accurately the delay between stroke onset and hospital arrival. This analysis excludes
in-patient stroke cases.
The date of stroke onset was recorded for 97% of cases (n=3078) but a stroke onset date and time was
only recorded in 54% of cases (n=1,723). It was recorded as unknown in 40% of cases (n=1,268).
The date of hospital arrival was recorded in 99% of cases (n=2,845) and the date and time of hospital
arrival was recorded in 94.8% of cases (n=3007). It was recorded as unknown in 1% of cases (n=37) with
no time recorded in 3% of cases (n=101). The number of cases analysable for time of onset to hospital
arrival is 1665, 52.5% increased from 46% in 2016.
Table 8 below outlines the median time from stroke symptom onset to hospital arrival but note the
reduced cohort available for this analysis, signifying a large portion of unknown, incorrect and/or missing
dates/times. For those cases that had times available, 61% arrived at hospital within four hours of
symptom onset, 53% within three hours and 47% within 2.5 hours (table 8). The Irish Heart
Foundation/HSE National Stroke Audit reported that 56% of patients arrived at hospital within 3 hours
(McElwaine et al, 2015).
10.9 9.9 9.9
30.5 30.8
36
0
5
10
15
20
25
30
35
40
2015 2016 2017
Per
cen
tage
National Stroke Mortality Rates 2015-2017
Ischaemic Stroke Haemorrhagic Stroke
14
Table 8: Time from stroke symptom onset to hospital arrival n=1665
*IQR = interquartile range, time by which 25% and 75% of patients arrived
The most recent clinical audit report from SSNAP states that the median time from onset to hospital arrival
in SSNAP was 2 hours and 50 minutes (IQR 1:28-8:46) (Royal College of Physicians 2017).
Table 9: Distribution of time from stroke symptom onset to hospital arrival (n=1,665)
Table 10 indicates a wide variation of onset to hospital arrival times. This information could be used
when reviewing time related emergency treatments such as thrombolysis.
Table 10. Time from stroke symptom onset to hospital arrival by hospital
Onset to Hospital Arrival Median IQR
Beaumont Hospital 01:31 00:49 02:04
Tallaght University Hospital 01:39 01:09 05:26
St Vincent’s University Hospital 01:53 01:13 03:40
Cavan General Hospital 02:16 01:32 05:17
Cork University Hospital 02:17 01:31 03:29
St Luke’s Hospital Kilkenny 02:20 01:24 05:14
Midland Regional Hospital Mullingar 02:21 01:30 09:42
Our Lady of Lourdes Drogheda 02:26 01:23 07:53
Naas General Hospital 02:30 01:34 05:07
St James’s Hospital 02:32 01:15 06:08
University Hospital Letterkenny 02:49 01:44 08:34
University Hospital Galway 03:03 01:41 13:58
Mayo University Hospital 03:12 02:00 06:00
University Hospital Waterford 03:12 01:48 09:10
Sligo University Hospital 03:14 01:40 06:40
Wexford General Hospital 04:01 02:00 06:10
Portiuncula Hospital 05:05 03:31 08:32
Mercy University Hospital 05:57 02:22 14:34
Bantry General Hospital 07:00 03:37 31:00
Median (IQR)*
Time (hh:mm) 1:53 (1:29-6:34)
< 2.5 hours < 3 hours < 4 hours
Time (%) 46.8 53.3 61.1
15
Hospital Length of Stay
Table 12 outlines the overall length of stay for stroke patients recorded on the stroke register. Hospital
length of stay can be related to the age of the patients and table 13 highlights the hospital length of stay
by age group. As expected, older patients have longer lengths of stay. The overall median length of stay
of stroke patients recorded on the stroke register remains at 9 days.
Table 12: Hospital Length of Stay (days, n=3,481)
Table 13: Hospital Length of Stay (days) by age group (n=3,281)
Stroke Care
Assessment by Stroke Team
Timely emergency department (ED) evaluation and stroke team assessment is paramount in review of all
stroke patients but in particular regarding the potential treatment of ischaemic stroke with thrombolysis.
Guidance from the American Heart Association/American Stroke Association advises that ED patients with
suspected acute stroke should be triaged with the same priority as acute myocardial infarction or serious
trauma, regardless of the severity of neurological deficits (Jauch et al, 2013). Figure 7 shows that where
data was available, 69% of stroke patients were seen by the stroke team within 3hrs of admission. This is
up from 54% in 2016.
Within the National Stroke Register, stroke teams are asked
to document the date and time of hospital arrival and also the
date and time that the patient was seen by the stroke team.
This enables calculation of the delay to review by the stroke
team. However, the reduced cohort available for this analysis
(2101) must be noted, signifying a large portion of missing
dates/times.
Median (IQR) Mean (±SD)
Length of stay 9 (5 – 19) 18.2 (±28.4)
< 65 Years 65 – 79 Years 80+ Years
Median (IQR) 7 (4 – 14) 9 (4 – 19) 11 (9-24)
Mean (±SD) 15.1 (±26.3) 18.3 (± 31.1) 20.3 (±25.9)
45%
11%13%
21%
10%
30mins 60mins 3hrs
24hrs >24hrs
16
Figure 7. Time seen by Stroke Team n=2101
The median time to assessment by the stroke
team after admission was 43 minutes; figure 8
reflects a significant improvement in timeliness
of assessment by the medical team.
Figure 8. Number of minutes to be seen by medical team 2013 - 2017.
Brain Scanning (CT or MRI)
Data in relation to CT or MRI brain scanning was available for 3323 patients and this includes the patients
who had a stroke as an inpatient. In total, 97% of patients had a CT or MRI scan after their stroke in their
hospital of admission with a further 2.8% of patients having a CT or MRI scan performed pre-admission or
in a previous hospital in cases of hospital transfer as per Table 14.
Table 14: Brain CT or MRI Performed n=3323, (Missing data = 158)
Data in relation to the timeliness of imaging has always been important in order to ensure prompt decision
to treat, however given recent advances in the acute phase of stroke it is even more important to become
aware of access to imaging and treatment within each hospital.
In 2018, a national quality improvement programme commenced in conjunction with the RCPI which aims
to reduce ‘door to decision to treat’ times. Baseline data from 2016 and 2017 will be valuable in its
evaluation. Table 15 indicates the ‘Door to Imaging’ times for each hospital.
N %
Yes 3214 97
No 10 0.3
Performed pre admission/hospital transfer 94 2.8
Unknown 5 0.2
0
200
400
600
800
2013 2014 2015 2016 2017
Min
ute
s
17
Table 15: Door to imaging median and interquartile range by hospital.
Thrombolysis
Administration of recombinant tissue
plasminogen activator (tPA/thrombolysis)
is a proven effective treatment for
ischaemic stroke and should be
administered as soon as possible after
onset of symptoms within a 4.5 hour
window in the absence of
contraindications. In this analysis the
denominator for the thrombolysis data is
different from the rest of this report at
3,133 as it interrogates both i63 and i64
codes to align with the National Stroke
KPIs. Table 16. Thrombolysis rates n=3133.
Table 16 shows that for patients with a principal diagnosis of i63 or i64, the IV thrombolysis rate was
11.9% when unknown and missing/not recorded cases were removed. SSNAP reported a thrombolysis
rate of 11.6% in their most recent report (Royal College of Physicians, 2017). Table 17 indicates the IV
thrombolysis rates by hospital.
Door to Imaging
Number of cases with DTI times recorded
Number of cases within 45mins N (%) Median IQR
Bantry General Hospital 54 7 (13) 01:13 00:56 - 01:59
Beaumont Hospital 219 96 (44) 00:52 00:23 - 03:21
Cavan General Hospital 17 5 (29) 01:10 00:29 - 03:51
Our Lady of Lourdes Drogheda 157 37 (24) 01:38 00:43 - 04:57
University Hospital Galway 277 112 (40) 01:11 00:20 - 05:38
St James's Hospital 193 73 (38) 01:14 00:28 - 03:23
St Luke’s Hospital Kilkenny 108 16 (15) 02:09 01:01 - 14:54
University Hospital Letterkenny 176 24 (14) 03:27 01:14 - 16:55
University Hospital Mayo 158 21 (13) 02:31 01:04 - 13:24
Mercy University Hospital 84 9 (11) 02:58 01:29 - 07:47
Midland Regional Hospital Mullingar 99 27 (27) 01:26 00:42 - 05:08
Naas General Hospital 123 56 (46) 00:48 00:16 - 03:42
Portiuncula Hospital 29 0 10:47 02:14 - 22:39
Sligo University Hospital 118 15 (13) 02:43 01:10 - 12:08
St Vincents University Hospital 233 74 (32) 01:05 00:36 - 03:34
Tallaght University Hospital 188 26 (14) 01:59 01:10 - 04:55
University Hospital Waterford 114 19 (17) 02:37 01:13 - 05:31
Wexford General Hospital 102 5 (5) 05:53 01:48 - 20:38
N %
Yes 363 11.6
No 1,397 44.6
Contraindicated 1306 41.7
Combined IV and intra-arterial
thrombolysis 5 0.2
Blank 62 1.9
18
Table 17: Principal Diagnosis of i63 or i64 n=3133 and thrombolysis rates.
The ‘Door to Needle’ time was
available in 76% (278) cases.
The median time from door to
needle nationally was 71
minutes with an interquartile
range of 50-101 minutes.
SSNAP UK reports a median
door to needle time of 52mins
(IQR 36 – 75).
Table 18. Door to Needle times to patients who received thrombolysis n=278.
i63 i64 cases TPA cases %TPA i63 cases
Mercy University Hospital 90 10 11.1%
Mayo University Hospital 171 13 7.6%
University Hospital Galway 270 26 9.6%
Naas General Hospital 126 32 25.4%
St Luke’s Hospital Kilkenny 91 17 18.7%
Bantry General Hospital 55 3 5.5%
Beaumont Hospital 369 51 13.8%
St James’s Hospital 186 38 20.4%
Sligo University Hospital 132 6 4.5%
Letterkenny University Hospital 176 16 9.3%
Midland Regional Hospital Mullingar 103 14 13.6%
Our Lady of Lourdes Drogheda 161 15 9.3%
Wexford General Hospital 120 4 3.3%
St Vincent’s University Hospital 240 17 7.1%
Tallaght University Hospital 204 29 14.2%
Cavan General Hospital 146 16 11.0%
University Hospital Waterford 98 9 9.2%
Cork University Hospital 337 52 15.4%
Portiuncula Hospital 58 0 N/A
TPA with DTN data
Median Time
Interquartile Range
Mercy 6 00:45 00:42 01:02
Mayo 8 00:51 00:27 01:06
Galway 25 00:51 00:30 01:26
Naas 24 00:51 00:27 01:06
Kilkenny 17 00:57 00:39 01:12
Bantry 2 00:57 00:51 01:04
Beaumont 51 00:58 00:28 01:28
James 35 01:06 00:49 01:28
Sligo 6 01:10 00:51 01:14
Letterkenny 12 01:12 01:07 01:28
Mullingar 10 01:37 01:03 02:03
Drogheda 12 01:25 00:57 02:17
Wexford 4 01:31 01:22 01:41
SVUH 15 01:33 01:07 02:14
Tallaght 29 01:34 01:02 02:15
Cavan 13 01:43 01:05 01:55
Waterford 9 01:45 01:11 02:02
19
Thrombectomy
Thrombectomy in stroke is the mechanical removal of a blood clot within the large vessels of the
cerebral circulation. Thrombectomy for acute stroke is provided by Beaumont Hospital on a 24 hour
basis, 7 days a week. Additionally, Cork University Hospital provides an 8-8 hour service, 5 days a week
for their surrounding network. Outside these hours, suitable patients may be transferred to Beaumont
Hospital for treatment. Data on thrombectomy is collected in Beaumont Hospital and Cork University
Hospital and recorded on the National Stroke Register. The National Thrombectomy Service produced
an annual report in 2017 and provides further detailed analysis of the thrombectomy service.
In 2017, 271 cases were recorded as having had a thrombectomy on the National Stroke Register. These
cases were referred from hospitals throughout the country including those not analysed in this report
therefore thrombectomy rate is not reportable in this report. The rate of thrombectomy reported in the
National Thrombectomy Service Annual Report is 5.6%.
Antithrombotic therapy
91.8% (3196/3481) had data recorded on antithrombotic therapy. Figure 9 indicates the number of
patients who were treated with antithrombotics. In 2017, 72.2% (2513/3481) were reported as treated
with antithrombotics. Figure10 shows that 76% (1923/2513) of cases were commenced on
antithrombotics within 24hrs.
Figure 9. Antithrombotic therapy n=3185 Figure 10. Start times for antithrombotics n=2513
79%
8%
13%
0%
Yes No Contraindicated Unknown
56%20%
8%
2% 14%
Day 1 Day 2 Within 7 Days
> 7Days Unknown
20
Atrial Fibrillation
93% (3236/3481) had data recorded on atrial
fibrillation (AF). 33% (1073/3236) of cases were
reported to have AF and 61.5% (660/1073) of those
cases were known to have AF prior to stroke. This was
reported as 57.2% in 2015.
Figure 11. No. of cases with Atrial Fibrillation n=3236 (245 missing data).
Of the cases that were known to have AF pre stroke 53%
(350/660) were prescribed anticoagulation pre stroke,
two thirds of which were prescribed NOACs. 61%
(74/121) of cases on warfarin pre stroke were not within
the 2-3INR range on admission. Table 19 indicates the
breakdown of Afib data by stroke type.
Figure 12 Afib diagnosis pre stroke.
Table 19 Breakdown of Ischaemic and Haemorrhagic Afib data
Secondary prevention data for patients with AF was available in 85.9% (922/1074) cases.
73.8% (680/922) of cases were prescribed
antiplatelet and/or anticoagulation on
discharge and in 84.4% (574/680) of those
cases the treatment was identified.
On discharge, 91% of cases with AF are on anticoagulation with the preference for NOAC prescribing.
Table 20. Secondary prevention for AF cases n=574 (106 missing data).
Stroke Type Afib known prior to stroke % (n)
On anticoagulation prior to stroke % (n)
Prescribed NOACs % (n)
Prescribed Warfarin % (n)
If on Warfarin was INR 2-3 on admission % (n)
Ischaemic n3020
18.8% (568/3020)
51.7 (294/568) 63.2 (186/294) 36.7 (108/294) 29.6 (32/108)
Haemorrhagic n461
19.9 (92/461) 58.7 (54/92) 68.5 (37/54) 31.5(17/54) 29.4 (5/17)
Secondary Prevention for AF % (n)
NOAC 85% (491/574)
Warfarin 5% (30/574)
Antiplatelet Therapy 6% (36/574)
Antiplatelet and Anticoagulant 3% (17/574)
33%
59%
5% 3%
Yes No Results pending Unknown
660
374
24
0
200
400
600
800
AF Dx PreStroke
No AF PreStroke
Unknown
21
Admission to Stroke Unit
The admission of patients to stroke units, staffed by appropriate specialists, has been shown in numerous
studies to reduce the rates of mortality and morbidity after stroke (European Stroke Organisation, 2008,
Jauch et al, 2013,). Table 21 shows that 70.6% of stroke patients were admitted to a stroke unit after
excluding not recorded data. This was 65.9% in 2016, 63.4% in 2015. Reasons for non-admission to the
stroke unit are documented in table 22 for the 1004 patients who were not admitted.
Table 21: Admission to Stroke Unit (n=3135, missing data = 146 (4.5%)
N %
Yes 2416 70.6%
No 1004 29.4%
A free text box was added in 2014 to provide further explanation for non-admission if required. The three
main reasons for selecting ‘other’ were: patients transferring to or from another hospital; end of life care;
and intensive care unit admission.
Table 22: Reasons for non-admission to stroke unit n=1004
N %
No stroke unit 191 19.0
Other 360 35.9
Bed not available 369 36.8
Infection control risk 13 1.2
Unknown 71 7.1
Table 23 indicates the percentage of cases admitted to a stroke unit by hospital. This is a National Stroke
KPI and the 2017 KPI result is 69.2%, consistent with the outcome of this report. The national target is
90%.
22
Hospital Registered Cases i61, i63
Admitted to Stroke Unit
% Admitted to Stroke Unit
Bantry General Hospital 56 51 91%
Beaumont Hospital 408 282 69%
Cavan General Hospital 153 96 63%
Our Lady of Lourdes Drogheda 185 159 86%
University Hospital Galway 312 234 75%
St James’s Hospital 218 177 81%
St Luke’s Hospital Kilkenny 114 96 84%
Letterkenny University Hospital* 191 N/A N/A
Mayo University Hospital 183 174 95%
Mercy University Hospital 96 62 65%
Midland Regional Hospital Mullingar 107 40 37%
Naas General Hospital 143 105 73%
Portiuncula Hospital 65 36 55%
Sligo University Hospital 144 140 97%
St Vincent’s University Hospital 275 186 68%
Tallaght University Hospital 214 183 86%
University Hospital Waterford 121 91 75%
Wexford General Hospital 122 42 34%
Cork University Hospital 374 263 70%
Grand Total 3481 2417 69% Table 23. Admission to a stroke unit
*No Stroke Unit
Swallow Screening in Stroke Units
Swallow screening is considered a good
indicator of organized stroke care. In 2017,
65.9% (1905) of cases had a swallow screen
completed, of those 32.3% (617) had the
swallow screen completed within four hours.
Figure 13. Swallow Screening n=3481
1905897
89 590
Yes No Unknown Blanks
23
Table 24 indicates that admission to a
stroke unit triples the rate of having a
swallow screen completed.
Table 24: Swallow screening rates in Stroke Units
Mood Screening
The reporting of mood screening was added into the dataset in 2017 and there was a 75.4% (2624)
response rate to this data point. The completion of a mood screen is low at 34.5% (620), excluding blank
cases, and work is on-going within the National Stroke Programme to complete a mood guidance
document. At present a depression pathway is available on the National Stroke Programme website
https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/management-of-post-
stroke-depression-care-pathway.pdf
As with the swallow screening admission
to a stroke unit increases the rate of
receiving assessment of mood as part of
comprehensive stroke care.
Table 25: Mood screening rates in Stroke Units
Stroke Unit Length of Stay (LOS)
The National Stroke Register captures the dates of admission and discharge from the stroke unit, which
allows calculation of length of stay for each patient in the stroke unit and also the proportion of the
patient’s overall stay in the hospital that was in the stroke unit.
There were 2416 patients admitted to the stroke unit and the length of stay was available for 2316 (96%)
patients.
Median (IQR) Mean (±SD)
Stoke unit LOS 9(4 – 15) 14 (±18.4)
Table 26: Length of Stay in Stroke Unit days, n=2316 (missing data = 100)
Admitted to a Stroke Unit n=2416
Not admitted to a Stroke Unit n=1004
Swallow Screen completed
67% (1619/2416) 28% (282/1004)
Admitted to a Stroke Unit n=2416
Not admitted to a Stroke Unit n=1004
Mood Screen completed
32.9% (570/2416) 11.1% (111/1004)
24
Outcomes
In 2017, the addition of pre-stroke and discharge Modified Rankin Score (MRS) was introduced. In 2017,
72% (2512) of cases had a pre-stroke MRS and 73% (2551) had a discharge MRS. 71% (2472) had a pre-
stroke MRS and discharge MRS recorded. Mortality results within this domain need to take into account
the sample size for analysis (71%). Online training was offered to all data inputters to support accurate
recording of the tool. It was agreed that results would be grouped as: no disability (0), Mild disability (1
or 2) and Moderate/Severe (3, 4 or 5), figure 14.
Figure 14. Pre-Stroke and Discharge Modified Rankin Score n=2472
MRS and Stroke Type
In 2017, the National Stroke Register recorded 87% (3019) ischaemic strokes (i63) and 13% (462)
haemorrhagic strokes (i61). Figures 15 and 16 indicates the outcomes by stroke type. An increased level
of disability and mortality is shown for haemorrhagic stroke. The mortality in this cohort is remarkably
similar to the national mortality by stroke type in NQAIS.
Figure 15. Ischaemic MRS Outcomes. Figure 16. Haemorrhagic MRS Outcomes.
27%
68%
34%
18%
26%
14%
13%
0
D I S C H A R G E M R S
P R E - S T R O K E M R S
M O D I F I ED R A N K I N S C O R E O U T C O M ES N = 2 4 7 2
0 1,2 3,4,5 6
29%
68%
35%
18%
25%
14%
11%
0%
D I S C H A R G E
P R E - S T R O K E
M O D I F I ED R A N K I N S C O R E O U T C O M ES - I S C H A EM I C N = 2 1 7 2
0 1,2 3,4,5 6
12%
66%
18%
16%
35%
18%
35%
0%
D I S C H A R G E
P R E - S T R O K E
M O D I F I ED R A N K I N S C O R E O U T C O M ES - H A EM O R R H A G E
N = 3 0 1
0 1,2 3,4,5 6
25
Multidisciplinary Team Assessment
The variables within the National Stroke Register relating to assessments by the multidisciplinary team,
including Clinical Nurse Specialist and Health and Social Care Professionals (HSCP), only ask if the
assessment was conducted.
In 2017, a HSCP specific dataset was designed, looking at the time frames within which the assessment
are carried out and other relevant variables. From 2018 data will be collected by HSCPs (physiotherapy,
occupational therapy and speech and language therapy) which will increase the level of data on in-patient
rehabilitation. We anticipate that this will take some time to embed into practice as it did for the main
register and will support HSCPs in this initiative.
Table 27 indicates that 81% of cases are assessed by a multidisciplinary team and 79% are assessed by a
Clinical Nurse Specialist in Stroke (table 28).
Table 27: Assessment by Multidisciplinary Team
Table 28: Assessment by Clinical Nurse Specialist/Advanced Nurse Practitioner
Clinical Nurse Specialist/Advanced Nurse
Practitioner n3481
N %
Yes 2755 79.1
No 593 17
Not Indicated 1 .03
Unknown 3 0.1
Missing/Not recorded 129 3.7
Multidisciplinary Team
N %
Yes 2,818 80.9
No 442 12.8
Unknown 221 6.3
26
Data regarding assessment by the various Health and Social Care Professionals is shown in tables 29 and
30. Removing the data for patients for whom an assessment was not indicated and also removing the
missing and unknown data shows that 98% of applicable patients received a Physiotherapy assessment,
96% received an Occupational Therapy assessment and 94% received a Speech and Language Therapy
assessment, 76% were seen by a Dietitian, 56% were seen by a Medical Social Worker and 11% saw a
psychologist. 73% were seen by a Clinical Nurse Specialist/Advanced Nurse Practitioner. However, the
proportion of missing data range between 20 and 30% and this needs to be taken into account and
addressed to ensure more accurate reporting of assessment by the Health and Social Care Professionals.
Table 29: Assessment by Physiotherapist, Occupational Therapist and Speech and Language Therapist (n=3,481)
Physiotherapist Occupational
Therapist
Speech &
Language
Therapist
N % N % N %
Yes 2635 75.7 2476 71 2055 59
No 49 1.4 87 3.2 138 3.9
Not Indicated 84 2.4 166 4.8 425 12.2
Unknown 2 0.1 1 .03 11 0.3
Missing/Not recorded 711 20.4 751 21 852 24.5
Table 30: Assessment by Dietitian, Medical Social Worker and Psychologist (n=3,481)
*Low referral rate may reflect low representation of psychologist on MDT as found in IHF/HSE National Stroke Audit
2015
Dietitian Medical Social Work Psychology*
N % N % N %
Yes 945 27.1 707 20.3 133 3.8
No 302 8.6 548 15.7 1080 31
Not Indicated 1103 31.6 990 28.4 890 25.5
Unknown 16 0.5 7 0.2 10 0.3
Missing/Not recorded 1115 32 1229 35.3 1368 39.3
27
Appendices
Appendix 1. National Stroke Register Steering Group Members
Prof. Joe Harbison, Consultant Stroke Physician, St. James’s Hospital- Chairperson
Dr Ronan Collin, Clinical Lead National Stroke Programme
Ms Ciara Breen, Occupational Therapist, University Hospital Galway
Deirdre Cunningham, Coding Manager, Beaumont Hospital
Ms Nora Cunningham, Clinical Nurse Specialist, University Hospital Limerick
Ms Trish Daly, Advanced Nurse Practitioner, Naas General Hospital
Dr Teresa Donnelly, Clinical Lead, MRH Tullamore
Dr Rachael Doyle, Consultant Geriatrician, Chairperson, IHF Council on Stroke
Mr Philip Dunne, I.T. Systems Support, Healthcare Pricing Office
Ms Emma Hickey, Clinical Nurse Specialist, Beaumont Hospital
Dr Frances Horgan, IHF Council on Stroke
Prof. Peter Kelly, Consultant Neurologist, Mater Hospital (Chair May2011–June 2013)
Ms Deirdre Lynch, Coding Manager, St Vincent’s University Hospital
Ms Joan McCormack, National Stroke Programme, Programme Manager, RCPI
Ms Hannah Murugan, St Luke’s Hospital, Kilkenny
Jackie Naughton, Coding Manager, Mercy University Hospital
Ms Imelda Noone, Advanced Nurse Practitioner, St Vincent’s University Hospital
Prof. Martin O’Donnell, Consultant Geriatrician, University Hospital Galway
Dr John Thornton, Consultant Radiologist, Clinical Stroke Lead, Beaumont Hospital
Ms Triona Dooley, Coding Manager, University Hospital Limerick
28
Appendix 2. National Stroke Register Dataset HIPE Portal Data Entry / Stroke (V3.0.2) 06 Dec 2016
Question Options Short Name
1. Which hospital was patient transferred from (if any) 0000 Not Applicable
0941 Children’s Crumlin
0101 St Columcille’s
0102 Naas General
0908 Mater Hospital
0910 SVUH
0925 Peamount Hospital
0955 Cappagh Orthopaedic
0940 Temple Street
0947 St Luke’s Rathgar
0904 SJH Dublin
0108 Connolly Blanchardstown
0912 Michaels Dun Laoghaire
0950 RVEEH
0960 National Rehabilitation
0930 Coombe Hospital
0932 Rotunda Dublin
0931 National Maternity Hosp
1270 Tallaght Hospital
1762 Josephs Raheny
0954 Clontarf Orthopaedic
1001 Blackrock Hospice
0600 Waterford
0601 St Luke’s KK
0605 Wexford
0602 Kilcreene
0607 Clonmel
0705 Finbar’s Cork
0704 Bantry
0913 Mercy Cork
0915 South Infirmary
0703 Mallow
0724 CUH
0726 Kerry
0301 Limerick Maternity
0300 Limerick
0302 Croom Limerick
0918 St Johns Limerick
0305 Ennis
0304 Nenagh
0803 Roscommon
0919 Portiuncula
0800 Galway
0802 Mayo
0801 Merlin Park
0203 Tullamore
0202 Mullingar
0201 Portlaoise
0500 Letterkenny
0501 Sligo
0922 Drogheda
0402 Cavan
0400 Louth County
0404 Monaghan
0403 Navan
8888 Other
Trans Hosp
1A. Why was the patient transferred 1 Thrombolysis
2 Thrombectomy
3 Neuro Surgery
8 Other
Trans Reason
1B. If other transfer reason, please specify Trans Reason Other
1C. If other transfer hospital, please specify Trans Hosp Other
2. Symptom onset date Onset Date
29
3. Symptom onset time (enter 9999 if unknown) Onset Time
3A. If symptom onset time is unknown, what date was the patient last known to be well
Last Well Date
3B. If symptom onset time is unknown, what time was the patient last known to be well
Last Well Time
4. Did the stroke occur while the patient was in hospital for treatment of another condition
1 Yes, 2 No
9 Unknown
Hosp Str
4A. If no, date of presentation to hospital Arr Date
4B. If no, time of presentation to hospital Arr Time
4C. If presentation time is unknown, was presentation to hospital within 4.5 hrs of symptom onset
1 Yes, 2 No
9 Unknown
Arr 4.5hrs
5. Medical team / Stroke team assessment date Assess Date
5A. Medical team / Stroke team assessment time Assess Time
6. Brain CT or MRI performed 1 Yes, 2 No
3 Performed pre adm / hosp transfer
9 Unknown
Imaging
6A. If yes, First Brain Imaging date Img Date
6B. If yes, First Brain Imaging time Img Time
7. Did the patient receive I.V. Thrombolysis (Key Performance Indicator) 1 Yes, 2 No
5 Contraindicated
Thrombolysis
7A. If yes, enter date Thromb Date
7B. If yes, enter time Thromb Time
7C. If yes, was intracerebral bleed seen on scan within 36 hrs 1 Yes, 2 No
9 Unknown
Intracereb Bleed
7D. If intracerebral bleed, was neuro deterioration associated with it 1 Yes, 2 No
9 Unknown
Neuro Deter Assoc
*8. Did the patient have thrombectomy in this hospital (Beaumont / CUH only) 1 Yes, 2 No Thrombectomy
8A. NIHSS pre-thrombectomy NIHSS Pre
8B1. Date of performance of non contrast CT Non Con CT Date
8B2. Time of performance of non contrast CT Non Con CT Time
8C1. Date of performance of non contrast CTA Non Con CTA Date
8C2. Time of performance of non contrast CTA Non Con CTA Time
8D1. Date of contact with the endovascular stroke centre Contact Endo Date
8D2. Time of contact with the endovascular stroke centre Contact Endo Time
8E1. Date of decision to transfer patient Trans Dec Date
8E2. Time of decision to transfer patient Trans Dec Time
8F1. Date of arrival at the endovascular stroke centre Date Arr Endo
8F2. Time of arrival at the endovascular stroke centre Time Arr Endo
8G1. Did the patient have repeat non invasive imaging in the endovascular stroke centre
1 Yes, 2 No
9 Unknown
Img Repeat
8G2. If yes, please specify 1 Non contrast CT
2 CTA
3 Perfusion CT
4 MRI
Img Type
8H. Site of most proximal occlusion 1 MCA 1
2 MCA 2
3 Basilar
4 ICA carotid T/L
5 ICA cervical segment
6 PCA
7 Vertebro basilar
Most Prox Occ
8J. Second occlusion site 2nd Occ Site
8K. Associated carotid stenosis greater than 50% 1 Yes, 2 No
9 Unknown
Assoc Carotid
30
8L1. TICI pre thrombectomy TICI Pre
8L2. TICI post thrombectomy TICI Post
8M1. Date of groin puncture Groin Punc Date
8M2. Time of groin puncture Groin Punc Time
8N1. Date of first pass 1st Pass Date
8N2. Time of first pass 1st Pass Time
8P1. Date of first reperfusion 1st Reperf Date
8P2. Time of first reperfusion 1st Reperf Time
8Q1. Date of final angio Final Angio Date
8Q2. Time of final angio Final Angio Time
8R. Immediate complications 0 Not Applicable
1 Haemorrhage
2 Embolus into separate vascular territory
3 Dissection
8 Other
9 Unknown
Imed Comp
8S. NIHSS 24 hour post-thrombectomy NIHSS Post
8T1. Following procedure was patient transferred immediately back to primary receiving hospital
1 Yes, 2 No
9 Unknown
Trans Prim Rec
8T2. If no, when was patient admitted to the endovascular stroke centre 1 0-3 hrs
2 3-12 hrs
3 12-24 hrs
4 24+ hrs
Trans Endo Centre
9. Was a swallow screen completed 1 Yes, 2 No
9 Unknown
Swallow
9A. If yes, was swallow screen completed within 4 hours of presentation 1 Yes, 2 No
9 Unknown
Swallow 4hrs
10. Modified Rankin Scale pre stroke 0 Zero
1 One
2 Two
3 Three
4 Four
5 Five
6 Six
9 Unknown
Pre Strk Rankin
11. Admitted to Stroke Unit (Key Performance Indicator) 1 Yes, 2 No Stroke Unit
11A. If yes, date admitted to Stroke Unit (Key Performance Indicator) SU Adm
11B. If yes, date discharged from Stroke Unit (Key Performance Indicator) SU Dis
11C. If no, reason why 1 No Stroke Unit
2 Bed Not Available
5 Infection Control Risk 8
Other
SU No
11C2. If other reason, please specify SU No Other
12. Allied Health Professional (AHP) Assessment 1 Yes, 2 No AHP
12A. If yes, Physiotherapy 1 Yes, 2 No
3 Not Indicated
9 Unknown
Physio
12B. If yes, Occupational Therapy 1 Yes, 2 No
3 Not Indicated
9 Unknown
Occup
12C. If yes, Speech and Language 1 Yes, 2 No
3 Not Indicated
9 Unknown
SLT
12D. If yes, Dietetics 1 Yes, 2 No
3 Not Indicated
9 Unknown
Dietet
31
12E. If yes, Medical Social Work 1 Yes, 2 No
3 Not Indicated
9 Unknown
MSW
12F. If Yes, Psychology 1 Yes, 2 No
3 Not Indicated
9 Unknown
Psyc
13. Was the patient assessed by Stroke Nurse Specialist 1 Yes, 2 No
9 Unknown
Assess SNP
13A. If no, reason why Assess SNP No
14. Multidisciplinary Meeting Case assessment 1 Yes, 2 No
3 Not Indicated
9 Unknown
Multidisc
14A. Was an assessment of mood completed and documented by a
member of the multi- disciplinary team
1 Yes, 2 No
3 Not Indicated
9 Unknown
Mood Assess
15. Does the patient have Symptomatic Carotid Stenosis 1 Yes, 2 No
9 Unknown
Stenosis
15A. If Symptomatic Carotid Stenosis, was the patient referred for Carotid Endarterectomy
1 Yes, 2 No
9 Unknown
Refer
Endarterectomy
15B. If Symptomatic Carotid Stenosis, was the patient referred for Carotid Stenting 1 Yes, 2 No
9 Unknown
Refer Stenting
16. New or Altered Antithrombotic Therapy prescribed for acute treatment 1 Yes, 2 No
3 Contraindicated
9 Unknown
Antithromb Acute
16A. If yes, Antiplatelet Or Anticoagulant (for acute treatment) start date Antiplatelet
17. Does the patient have Atrial Fibrillation 1 Yes, 2 No
4 Results Pending
9 Unknown
Atrial Fib
17A. If Atrial Fibrillation, was atrial fibrillation known prior to stroke onset 1 Yes, 2 No
9 Unknown
AFib Prior
17B1. If yes, please specify Antiplatelet / Anticoagulant - prior to stroke 0 NOAC
1 Warfarin
5 Aspirin
6 Clopidogrel
7 Other Antiplatelet
8 Dual Antiplatelet Therapy
9 Antiplatelet & Anticoagulant
Anticoag Prior
17C. If atrial fibrillation known prior to stroke onset, and Warfarin, was INR 2-3 at Stroke onset
1 Yes, 2 No
9 Unknown
INR 2-3
17D. If Atrial Fibrillation, Anticoagulation prescribed for secondary prevention 1 Yes, 2 No
9 Unknown
Anticoag 2nd
17D1. If yes, please specify Antiplatelet / Anticoagulant - on discharge 0 NOAC
1 Warfarin
5 Aspirin
6 Clopidogrel
7 Other Antiplatelet
8 Dual Antiplatelet Therapy
9 Antiplatelet & Anticoagulant
Anticoag Discharge
17D2. If no, please enter reason documented 1 No reason documented
2 Major bleeding (prior history)
3 Severe illness (e.g. cancer, dementia)
04 Poor compliance (known or
suspected)
5 Patient refused anticoagulation
6 Alcohol excess
7 Falls
8 Extreme frailty
9 Liver disease
Anticoag Doc
32
18. Modified Rankin Scale on discharge 0 Zero
1 One
2 Two
3 Three
4 Four
5 Five
6 Six
9 Unknown
On Dis Rankin
19. Discharge destination 1 Home
2 Patient died
3 Discharge to long term care
4 Discharge to off-site rehab 5
Transfer to referring hosp
6 Transfer to other hosp for on-going
stroke care
7 Home with ESD
8 Other
9 Unknown
Dis Dest
*Q8 is answered in Beaumont Hospital and Cork University Hospital only.
33
References
European Stroke Organisation (2008) Executive Committee and the ESO Writing Committee. Guidelines
for the management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008;25:457-
507.
Horgan F, Hickey A, McGee H, O’Neill D, on behalf of INASC Team (2008). Irish National Audit of Stroke
Care: Main Report. Dublin. Irish Heart Foundation.
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr,
Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; on behalf of the
American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral
Vascular Disease and Council on Clinical Cardiology (2013) . Guidelines for the early management of
patients with acute ischaemic stroke: a guideline for healthcare professionals from the American Heart
Association/American Stroke Association. Stroke 2013;44:870-947.
McElwaine P, McCormack J, Harbison J on behalf of the National Stroke Programme Audit Steering Group
(2015). Irish Heart Foundation /HSE National Stroke Audit 2015.
National Office of Clinical Audit (2016) National Audit of Hospital Mortality. RCSI.
National Patient Safety Office (2017) National Healthcare Quality Reporting System. Department of
Health. Dublin
National Quality Assurance and Improvement System (2018) https://www.healthatlasireland.ie/
Accessed on 17/7/18
Royal College of Physicians (2016) National Clinical Guideline for Stroke. 5th Edition. London. RCP.
Royal College of Physicians (2017) Sentinel Stroke National Audit Programme. London. RCP
Accessed on 17/7/18 https://www.strokeaudit.org/results/Clinical-audit/National-Results.aspx